IFG Advisory’s AbbVie ABBV Stock Holding History

IFG Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7.37M	Buy	39,701 +1,297	+3%	+$241K	0.37%	71
2025 Q1	$8.05M	Buy	38,404 +880	+2%	+$184K	0.45%	54
2024 Q4	$6.67M	Sell	37,524 -54	-0.1%	-$9.6K	0.38%	67
2024 Q3	$7.42M	Buy	37,578 +383	+1%	+$75.6K	0.47%	48
2024 Q2	$6.38M	Buy	37,195 +1,001	+3%	+$172K	0.41%	53
2024 Q1	$6.59M	Sell	36,194 -1,113	-3%	-$203K	0.49%	44
2023 Q4	$5.78M	Buy	37,307 +13,022	+54%	+$2.02M	0.42%	51
2023 Q3	$3.62M	Buy	24,285 +693	+3%	+$103K	0.3%	82
2023 Q2	$3.18M	Sell	23,592 -934	-4%	-$126K	0.28%	99
2023 Q1	$3.91M	Buy	24,526 +2,084	+9%	+$332K	0.37%	66
2022 Q4	$3.63M	Sell	22,442 -6,042	-21%	-$976K	0.36%	65
2022 Q3	$3.82M	Buy	28,484 +7,186	+34%	+$964K	0.35%	65
2022 Q2	$3.26M	Sell	21,298 -3,749	-15%	-$574K	0.35%	60
2022 Q1	$4.06M	Sell	25,047 -1,298	-5%	-$210K	0.41%	53
2021 Q4	$3.57M	Buy	26,345 +2,445	+10%	+$331K	0.35%	63
2021 Q3	$2.58M	Buy	23,900 +571	+2%	+$61.6K	0.28%	82
2021 Q2	$2.63M	Sell	23,329 -3,503	-13%	-$394K	0.29%	74
2021 Q1	$2.9M	Buy	26,832 +289	+1%	+$31.3K	0.36%	67
2020 Q4	$2.84M	Sell	26,543 -8,569	-24%	-$918K	0.39%	60
2020 Q3	$3.08M	Buy	35,112 +1,121	+3%	+$98.2K	0.5%	43
2020 Q2	$3.34M	Buy	33,991 +4,343	+15%	+$426K	0.6%	35
2020 Q1	$2.26M	Buy	29,648 +9,716	+49%	+$740K	0.5%	47
2019 Q4	$1.76M	Sell	19,932 -341	-2%	-$30.2K	0.32%	87
2019 Q3	$1.54M	Buy	20,273 +2,794	+16%	+$212K	0.3%	94
2019 Q2	$1.27M	Buy	17,479 +328	+2%	+$23.9K	0.23%	93
2019 Q1	$1.38M	Buy	17,151 +338	+2%	+$27.2K	0.26%	85
2018 Q4	$1.55M	Sell	16,813 -16,060	-49%	-$1.48M	0.37%	65
2018 Q3	$3.11M	Buy	32,873 +1,051	+3%	+$99.4K	0.58%	32
2018 Q2	$2.95M	Sell	31,822 -13	-0%	-$1.2K	0.61%	34
2018 Q1	$3.01M	Sell	31,835 -3,924	-11%	-$371K	0.67%	30
2017 Q4	$3.46M	Buy	+35,759	New	+$3.46M	0.78%	28